… to assess therapy responses and obtain routine … tumor response or progression in patients
with lung cancer by using thin-section CT and a semiautomated algorithm to calculate tumor …

… for tumor response in … lung cancer–related symptoms and relatively good functional status,
which was consistent with a European Organization for Research and Treatment of Cancer …

BACKGROUND AND PURPOSE: Prediction of local failure in radiotherapy patients with non-small
cell lung cancer (NSCLC) remains a challenging task. Recent evidence suggests that …

… is no correlation between tumor response and tumor perfusion changes in patients treated
with chemotherapy, possibly because cytotoxic drugs may not affect tumor microvasculature. …

A high incidence of interstitial lung disease (ILD) has been reported in patients with non-small
cell lung cancer (NSCLC) treated with gefitinib in Japan. We retrospectively analyzed 112 …

… was tumor response, determined by measuring percent reduction in the largest tumor
diameter … In addition, we determined tumor response using the standard RECIST classification. …

… the key role in lung cancer care. This article describes the origin and importance of tumor
response assessment, presents the recent genomic discoveries in lung cancer and therapies …

… Therefore, the accurate CT tumor measurement and response assessment in advanced …
The purpose of this study is to compare CT tumor measurement and tumor response …

… We included 104 patients (30 with a tumor response, 74 non-responders, 2 responses not
evaluable due to early death); 63 patients provided T1 samples. All patients were treated with …

… in tumor microenvironment. The population of regulatory T cells (Tregs) plays a crucial role
in this inhibition of immune response. … was found in lung cancer cells and in tumor infiltrating …